rofecoxib has been researched along with Syndrome in 4 studies
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the influence of low dose rofecoxib on inflammatory mediators and prostacyclin synthesis in patients with acute coronary syndromes (ACS) in a short-term follow up." | 9.11 | Low dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes. ( Dobrzycki, S; Kamiński, KA; Kralisz, P; Kuklińska, AM; Modrzejewski, W; Musiał, WJ; Sobkowicz, B; Stec, S; Wojtkowska, I, 2005) |
| "To assess the influence of low dose rofecoxib on inflammatory mediators and prostacyclin synthesis in patients with acute coronary syndromes (ACS) in a short-term follow up." | 5.11 | Low dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes. ( Dobrzycki, S; Kamiński, KA; Kralisz, P; Kuklińska, AM; Modrzejewski, W; Musiał, WJ; Sobkowicz, B; Stec, S; Wojtkowska, I, 2005) |
| "Gitelman's syndrome is manifested by hypokalemic alkalosis, hypomagnesemia, hypocalciuria, normotensive hyperreninemia and hyperaldosteronism." | 1.31 | Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman's syndrome. ( Farfel, Z; Gurevitz, O; Mayan, H, 2002) |
| "Hyperprostaglandin E syndrome/antenatal Bartter syndrome (HPS/aBS) is a congenital salt-losing tubulopathy with an induced expression of cyclooxygenase-2 (COX-2) in the macula densa probably leading to hyperreninemia." | 1.31 | Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. ( Brochhausen, C; Jeck, N; Kömhoff, M; Nüsing, RM; Reinalter, SC; Seyberth, HW; Watzer, B, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mayan, H | 1 |
| Gurevitz, O | 1 |
| Farfel, Z | 1 |
| Monakier, D | 1 |
| Mates, M | 1 |
| Klutstein, MW | 1 |
| Balkin, JA | 1 |
| Rudensky, B | 1 |
| Meerkin, D | 1 |
| Tzivoni, D | 1 |
| Kuklińska, AM | 1 |
| Musiał, WJ | 1 |
| Kamiński, KA | 1 |
| Kralisz, P | 1 |
| Modrzejewski, W | 1 |
| Sobkowicz, B | 1 |
| Dobrzycki, S | 1 |
| Stec, S | 1 |
| Wojtkowska, I | 1 |
| Reinalter, SC | 1 |
| Jeck, N | 1 |
| Brochhausen, C | 1 |
| Watzer, B | 1 |
| Nüsing, RM | 1 |
| Seyberth, HW | 1 |
| Kömhoff, M | 1 |
2 trials available for rofecoxib and Syndrome
| Article | Year |
|---|---|
Rofecoxib, a COX-2 inhibitor, lowers C-reactive protein and interleukin-6 levels in patients with acute coronary syndromes.
Topics: Acute Disease; Angina, Unstable; C-Reactive Protein; Coronary Disease; Cyclooxygenase Inhibitors; Do | 2004 |
Low dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antichol | 2005 |
2 other studies available for rofecoxib and Syndrome
| Article | Year |
|---|---|
Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman's syndrome.
Topics: Adult; Alkalosis; Calcium; Cyclooxygenase Inhibitors; Humans; Hyperaldosteronism; Hypokalemia; Lacto | 2002 |
Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome.
Topics: Adolescent; Adult; Bartter Syndrome; Child; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxyg | 2002 |